Drilldown: Medicines
Appearance
Medicines > fda max
:
Indication-specific
or
~10 mg/d typical
& onset:
Postprandial glucose effect within days; HbA1c by 12 weeks 
:
Indication-specific
or
~10 mg/d typical
& onset:
Postprandial glucose effect within days; HbA1c by 12 weeks 
Use the filters below to narrow your results.
There are no results for this report.

